Abstract
Objective: The predominant mechanism of early graft failure after coronary artery bypass grafting is associated with benefit of antiplatelet treatment of drugs like Acetyl-salicylic acid (ASA). The mechanisms for ASA resistance are multifactorial and can be screened by laboratory tests.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
